Glucose-Activated Switch Regulating Insulin Analog Secretion Enables Long-term Precise Glucose Control in Mice With Type 1 Diabetes
Diabetes · 2023
DOI: 10.2337/db22-0860 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2023. Verfasst von Lifang Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin-Secreting Cells, Hyperglycemia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, the International Cooperative Project of Sichuan Province on Science and Technology Innovation, the Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Genetic modification of non–β-cells to produce insulin is a promising therapeutic strategy for type 1 diabetes; however, it is associated with issues, including biosafety and precise regulation of insulin supply. In this study, a glucose-activated single-strand insulin analog (SIA) switch (GAIS) was constructed to achieve repeatable pulse activation of SIA secretion in response to hyperglycemia. In the GAIS system, the conditional aggregation domain–furin cleavage sequence–SIA fusion protein was encoded by the intramuscularly delivered plasmid and temporarily kept in the endoplasmic reticulum (ER) because it binds to the GRP78 protein; then, upon hyperglycemia, the SIA was released and secreted into the blood. In vitro and in vivo experiments systematically demonstrated the effects of the GAIS system, including glucose-activated and repeatable SIA secretion, long-term precise blood glucose control, recovered HbA1c levels, improved glucose tolerance, and ameliorated oxidative stress. Additionally, this system offers sufficient biosafety, as evidenced by the assays of immunological and inflammatory safety, ER stress, and histological evaluation. Compared with the viral delivery/expression system, the ex vivo implantation of engineered cells, and the exogenous inducer system, the GAIS system combines the advantages of biosafety, effectiveness, persistence, precision, and convenience, providing therapeutic potential for the treatment of type 1 diabetes. Article Highlights We undertook this study to establish a glucose-responsive single-strand insulin analog (SIA) self-supply system in vivo. We sought to determine whether the endoplasmic reticulum (ER) can serve as a safe and temporary repository to store designed fusion proteins and release SIAs under hyperglycemic conditions for efficient blood glucose regulation. The intramuscularly expressed plasmid-encoded conditional aggregation domain–furin cleavage sequence–SIA fusion protein can be temporarily stored in the ER, and the SIA can be released under the stimulation of hyperglycemia, resulting in efficient and long-term regulation of stable blood glucose in mice with type 1 diabetes (T1D). The glucose-activated SIA switch system provides applicable potential for T1D therapy, integrating regulation and monitoring of blood glucose levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu, Sichuan, China.
- West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Traditional Chinese Medicine (TCM) Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of TCM, Chengdu, Sichuan, China.
ORCID-Profile: Gang Wang
Förderung
- the National Natural Science Foundation of China
- the International Cooperative Project of Sichuan Province on Science and Technology Innovation
- the Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
Zitieren
APA
Xie, L., Lu, W., Zhang, Y., Deng, L., Liu, M., Gao, H., Xie, C., & Wang, G. (2023). Glucose-Activated Switch Regulating Insulin Analog Secretion Enables Long-term Precise Glucose Control in Mice With Type 1 Diabetes. Diabetes. https://doi.org/10.2337/db22-0860
Vancouver
Xie L, Lu W, Zhang Y, Deng L, Liu M, Gao H, et al. Glucose-Activated Switch Regulating Insulin Analog Secretion Enables Long-term Precise Glucose Control in Mice With Type 1 Diabetes. Diabetes. 2023. doi:10.2337/db22-0860
BibTeX
@article{Xie2023,
author = {Xie, Lifang and Lu, Wanling and Zhang, Yanhan and Deng, Lu and Liu, Ming and Gao, Hong and Xie, Chunguang and Wang, Gang},
title = {Glucose-Activated Switch Regulating Insulin Analog Secretion Enables Long-term Precise Glucose Control in Mice With Type 1 Diabetes},
journal = {Diabetes},
year = {2023},
doi = {10.2337/db22-0860}
}
EUVIMED